类风湿关节炎患者半乳糖凝集素-3水平与血管疾病指标的关联
在124例无临床心血管疾病的类风湿关节炎患者中,评估半乳糖凝集素-3与冠状动脉钙化评分、主动脉炎症(FDG PET/CT)及心肌血流储备的关联。多变量分析显示较高的半乳糖凝集素-3水平与较高的主动脉SUV独立相关(β=0.1786,p=0.002),而与冠状动脉钙化评分和心肌血流储备无显著关联。作者认为半乳糖凝集素-3可能是类风湿关节炎患者动脉粥样硬化炎症性且潜在可逆阶段的生物标志物,而非后期钙化阶段。
要点
- 在无临床心血管疾病的类风湿关节炎患者中,较高的血清半乳糖凝集素-3水平与较高的主动脉炎症(主动脉SUV)独立相关。
- 半乳糖凝集素-3水平与冠状动脉钙化评分及心肌血流储备无显著关联。
- 作者认为半乳糖凝集素-3可能是类风湿关节炎患者动脉粥样硬化炎症性且潜在可逆阶段的生物标志物。
核心结论
- 在无临床心血管疾病的类风湿关节炎患者队列中,较高的血清半乳糖凝集素-3水平与较高的主动脉炎症水平独立相关,但与冠状动脉钙化评分或心肌血流储备无显著关联。
- 作者认为半乳糖凝集素-3可能是类风湿关节炎患者动脉粥样硬化炎症性且潜在可逆阶段的生物标志物,而非后期钙化阶段的生物标志物。
研究设计与样本
- 类风湿关节炎患者且无临床心血管疾病者接受冠状动脉钙化评分、主动脉炎症(使用18氟脱氧葡萄糖正电子发射计算机断层显像[FDG PET/CT])及心肌血流储备评估。
- 主动脉FDG摄取以标准化摄取值(SUV)测量;构建广义线性模型探讨半乳糖凝集素-3水平与冠状动脉钙化评分、主动脉SUV及心肌血流储备的关联。
主要发现
- 共分析124例类风湿关节炎患者,平均年龄57岁,82%为女性,45%为西班牙裔,中位类风湿关节炎病程6.8年,75%血清阳性,中位CDAI 16,33%使用泼尼松,89%使用改善病情抗风湿药,中位冠状动脉钙化评分0,中位主动脉SUV 2.59,平均心肌血流储备2.86,中位半乳糖凝集素-3水平8.54 ng/mL。
- 单变量分析中,较高的半乳糖凝集素-3水平与较高的主动脉SUV相关(p=0.007),但与冠状动脉钙化评分和心肌血流储备无显著关联。
- 多变量分析中,较高的半乳糖凝集素-3水平仍与较高的主动脉SUV显著相关(β系数=0.1786,p值=0.002)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Galectin-3 is a beta-galactoside-binding lectin and is a marker of cardiovascular disease (CVD) in the general population. It may also play a role in joint inflammation. We asked whether serum galectin-3 is a useful marker of subclinical vascular disease in patients with rheumatoid arthritis (RA). METHODS: RA patients without clinical CVD underwent assessment of coronary artery calcium (CAC) score, aortic inflammation (using 18Fluorodeoxyglucose positron emission-computed tomography [FDG PET/CT]), and myocardial flow reserve (MFR). Aorta FDG uptake was measured as standardized uptake values (SUV). Generalized linear models were constructed to explore the associations of galectin-3 levels with CAC score, aortic SUV, and MFR. RESULTS: A total of 124 RA patients (mean age 57; 82 % women, 45 % Hispanic; median RA duration 6.8 years; 75 % seropositive; median CDAI 16; 33 % on prednisone; 89 % on DMARDs; median CAC score 0; median aorta SUV 2.59; mean MFR 2.86; median galectin-3 level 8.54 ng/mL) were analyzed. In univariable analysis, higher galectin-3 levels were associated with higher aortic SUV (p = 0.007) but CAC score and MFR were not. In multivariable analysis, higher galectin-3 level remained significantly associated with higher aortic SUV (ß Coefficient=0.1786, p value=0.002). CONCLUSION: In our cohort of RA patients without clinical CVD, higher serum galectin-3 levels were independently associated with higher levels of aortic inflammation, but not CAC score or MFR. This suggests that galectin-3 may be a biomarker for an inflammatory and potentially reversible stage, but not a later (calcified) stage, of atherosclerosis in patients with RA.
引用
- Nussdorf A, Park E, Amigues I, et al. Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2024. PMID: 38244444. doi:10.1016/j.semarthrit.2023.152357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。